Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-21-000039

Pres. Diagnostics & Genom sold 823 shares at $388.45 ($319,694)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · Pres. Diagnostics & Genom

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-05 Sale : show line 1 in the form −823 $388.45 $319,694 845 D
Open-market sales · 823 sh · avg $388.45 · $319,694
Loading xslF345X03/edgar.xml…